Tag - medicine

 
 

MEDICINE

Japan Times
WORLD
Oct 8, 2021
Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11
The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.
Japan Times
BUSINESS / Companies
Oct 8, 2021
COVID-19 pill sales could hit $2 billion, drugmaker Shionogi says
Competition to snag a piece of the COVID pill market is fierce, as the world adjusts to the virus being endemic.
Japan Times
WORLD / Science & Health / FOCUS
Oct 7, 2021
A Chilean tree holds hope for new vaccines — if supplies last
Quillay trees, technically known as Quillaja saponaria, are rare evergreens native to Chile that have long been used by the indigenous Mapuche people to make soap and medicine.
Japan Times
WORLD / Science & Health
Oct 7, 2021
In major breakthrough, WHO backs malaria vaccine rollout for Africa's children
The WHO says 94% of malaria cases and deaths occur in Africa, a continent of 1.3 billion people.
Japan Times
COMMENTARY / Japan
Oct 3, 2021
How Japan’s new PM can take a lead in improving global health
Prime Minister Suga's successor has a chance at becoming a global leader by helping end COVID-19 elsewhere in the world — a move that could also see Japan advance its foreign policy goals.
Japan Times
JAPAN
Oct 2, 2021
Japan urges prefectures to beef up medical systems ahead of winter virus wave
The health ministry has called for expanding the number of available beds nationwide on the assumption that the next wave of the virus could be at least as bad as this summer's fifth wave.
Japan Times
WORLD / FOCUS
Oct 2, 2021
Nobel Prize in medicine for COVID-19 vaccine? It may be too soon.
Among those seen by other scientists as potential winners are Hungarian-born Katalin Kariko and American Drew Weissman for their work on what are known as messenger ribonucleic acid (mRNA) vaccines.
Japan Times
WORLD / Science & Health
Oct 2, 2021
Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths
An experimental antiviral pill developed by Merck & Co. could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19.
Japan Times
COMMENTARY / World
Sep 30, 2021
Singapore's lauded COVID-19 response overlooked a major factor: fear
Singapore's case count is low by global standards, but a recent spike is staggering for a country that had all but eliminated COVID-19 before the delta variant emerged.
Japan Times
COMMENTARY / World
Sep 29, 2021
Liars may get COVID-19 boosters before those in need
Who will get the booster shots? Sadly, the answer is too many of the wrong people and too few of the right ones, adding more messiness to the rollout process.
Japan Times
JAPAN / Science & Health
Sep 27, 2021
Japan approves second drug for mildly ill COVID-19 patients
Sotrovimab was given the green light three weeks after GlaxoSmithKline's Japan unit submitted its application for the antibody treatment to the health ministry.
Japan Times
WORLD
Sep 20, 2021
Pfizer COVID-19 shot safely bolsters antibodies in younger kids
In a trial, two shots of a 10 microgram dose — one-third of the adult shot — produced antibody levels comparable to those seen in a trial of 16- to 25-year-olds who got the adult dose.
Japan Times
JAPAN / FOCUS
Sep 19, 2021
Home COVID-19 care surged as Japan's hospitals filled up, but treatment options were limited
Providing at-home treatment for coronavirus patients presents an entirely different dilemma for the nation's already exhausted medical personnel.
Japan Times
COMMENTARY / World
Sep 15, 2021
The explanation for seemingly irrational COVID-19 behavior
Before the vaccines came along, it made great sense to enforce masking norms. If infections could be shifted into the future, a vaccinated citizenry would be much better protected.
Japan Times
JAPAN / FOCUS
Sep 14, 2021
The hospital conundrum: Why Tokyo’s health system is overflowing with COVID-19 patients
Many hospitals — both those that are private as well as some nationally managed institutions — have been slow to set aside beds for infected patients.
Japan Times
COMMENTARY / World
Sep 14, 2021
The U.K.’s bizarre $1.7 billion vaccine rug-pull
The British government abruptly canceled its supply contract, having found Valneva in breach of its obligations without specifying how — something Valneva contests.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?